Результаты поиска - Paul Little
- Отображение 1 - 3 результаты of 3
-
1
Feasibility trial of a new digital training package to enhance primary care practitioners' communication of clinical empathy and realistic optimism. по Felicity Bishop, Jeremy Howick, Jane Vennik, Jennifer Bostock, Paul Little, Christian Mallen, Leanne Morrison, Mary Steele, Beth Stuart, Stephanie Hughes, Kirsten Smith, Mohana Ratnapalan, Emily Lyness, Hajira Dambha-Miller, Riya Tiwari, Clare Lockyer-Stevens, Hazel Everitt
Опубликовано 2025-01-01<h4>Background</h4>Patients can benefit when primary care practitioners communicate clinical empathy and optimism during consultations, but previous training interventions for practitioners are overly time-consuming and evidence on patient outcomes is limited. This study assessed the fea...
Полный текст
Статья -
2
Internet and telephone intervention to support patients discontinuing long-term antidepressants in primary care: the REDUCE research programme including RCT по Tony Kendrick, Beth Stuart, Hannah Bowers, Mahboobeh Haji Sadeghi, Helen Page, Christopher Dowrick, Michael Moore, Mark Gabbay, Geraldine Leydon, Guiqing Lily Yao, Shihua Zhu, Paul Little, Gareth Griffiths, Glyn Lewis, Carl May, Joanna Moncrieff, Chris F Johnson, Una Macleod, Simon Gilbody, Rachel Dewar-Haggart, Samantha Williams, Wendy O’Brien, Riya Tiwari, Catherine Woods, Tasneem Patel, Naila Khan, Emma Maund, Nadja van Ginneken, Amy Din, Claire Reidy, Rebecca Lucier, Bryan Palmer, Taeko Becque, Yumna Masood, Natalie Thompson, Ellen van Leeuwen, Marta Glowacka, Adam WA Geraghty
Опубликовано 2025-07-01Background There is significant concern about increasing long-term antidepressant use in Western countries, much of which is not evidence-based. Median duration of treatment is more than 2 years in the United Kingdom, and more than 10% of adults are taking antidepressants, risking potentially signif...
Полный текст
Статья -
3
Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): protocol for a randomised controlled adaptive platform trial of treatments for acute... по Catherine Hudon, Kris Aubrey-Bassler, Vivian R Ramsden, Machelle Wilchesky, Paul Little, Michelle Greiver, Rahim Moineddin, Ryan Zarychanski, Jean-Eric Tarride, Annie Leblanc, Peter Jüni, Dee Mangin, Robert Fowler, Srinivas Murthy, Jennifer Rayner, Alexander Singer, Yoav Keynan, Simone Dahrouge, Emily Gard Marshall, Rita McCracken, Sabrina T Wong, David J A Jenkins, Kerry McBrien, Nav Persaud, Anita Srivastava, Jennifer Isenor, Todd C Lee, Christopher C Butler, John C Marshall, Stephanie Garies, Valeria E Rac, Ross E G Upshur, Peter Selby, Marie-Thérèse Lussier, Sarvesh Logsetty, Andrew David Pinto, Melissa Andrew, Brianne Wood, Emily G McDonald, Amanda Condon, Aisha Lofters, Christine Leong, Lynora Saxinger, Rachel Walsh, Abhimanyu Sud, Sylvain Lother, Jean-Sébastien Paquette, David Barber, Brendan Barrett, Rae Spiwak, Sakina Walji, Ali Damji, Banafshe Hosseini, Bruno R. da Costa, Peter Daley, Noah Crampton, Jennifer Hulme, Rosemarie Lall, Laura Maclaren, Brianna Orava, Jay Jae Hee Park, Diana C. Sanchez-Ramirez, Haolun Shi, Deanna Telner, Barb Zelek, Jolanta Piszczek, Daniel Warshafsky
Опубликовано 2025-08-01Introduction SARS-CoV-2 is now endemic and expected to remain a health threat, with new variants continuing to emerge and the potential for vaccines to become less effective. While effective vaccines and natural immunity have significantly reduced hospitalisations and the need for critical care, out...
Полный текст
Статья